Sanofi has stopped recruiting participants for its COVID-19 hydroxychloroquine trials. The company will also no longer supply the drug to treat COVID-19 until concerns about safety are cleared up. (Reuters)

Official guidelines for coronavirus may drastically change the corporate office. Recommendations from the Centers for Disease Control and Prevention urge temperature checks, desk shields, no mass transit and other measures to control the spread of coronavirus in offices. (The New York Times)

Several diabetes drugs have been recalled due to high levels of a cancer-causing substance. The Food and Drug Administration told five drugmakers to recall metformin drugs after lab tests. However, patients should continue taking the treatment drug until their doctor can prescribe a replacement. (Associated Press)

New York City is on track to begin reopening on June 8. The city will begin phase one of reopening in early June, as new cases and deaths continue to fall and hospitals become less overwhelmed with COVID-19 patients. (CNBC)

AbbVie’s fibroids drug was approved by the Food and Drug Administration. The drug is the first non-surgical option to manage heavy menstrual bleeding associated with fibroids. (Reuters)